| Abstrakt: |
Keywords for this news article include: University of Ilorin, Pharmaceuticals, Proinsulin, Hyperinsulinism, Peptide Hormones, Peptide Proteins, Insulin Resistance, Drugs and Therapies, Health and Medicine, Risk and Prevention, Glucose Metabolism Disorders, Endocrine System Diseases and Conditions, Nutritional and Metabolic Diseases and Conditions. Drugs and Therapies, Endocrine System Diseases and Conditions, Glucose Metabolism Disorders, Health and Medicine, Hyperinsulinism, Insulin Resistance, Nutritional and Metabolic Diseases and Conditions, Peptide Hormones, Peptide Proteins, Pharmaceuticals, Proinsulin, Risk and Prevention Keywords: Drugs and Therapies; Endocrine System Diseases and Conditions; Glucose Metabolism Disorders; Health and Medicine; Hyperinsulinism; Insulin Resistance; Nutritional and Metabolic Diseases and Conditions; Peptide Hormones; Peptide Proteins; Pharmaceuticals; Proinsulin; Risk and Prevention EN Drugs and Therapies Endocrine System Diseases and Conditions Glucose Metabolism Disorders Health and Medicine Hyperinsulinism Insulin Resistance Nutritional and Metabolic Diseases and Conditions Peptide Hormones Peptide Proteins Pharmaceuticals Proinsulin Risk and Prevention 327 327 1 10/16/23 20231017 NES 231017 2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Data detailed on insulin resistance have been presented. [Extracted from the article] |
